NOF to Exhibit and Present at PEGS BOSTON 2026
NOF to Exhibit and Present at PEGS BOSTON 2026
Boston, MA, USA (May 11 - 15, 2026)
NOF CORPORATION is pleased to announce its participation in the upcoming 22nd Annual PEGS BOSTON 2026, which will be held at the Omni Boston Hotel at the Seaport, Boston, MA USA from May 11 to 15. The company is a Corporate Sponsor in the event.
The Conference website: https://www.pegsummit.com/
As part of the event, NOF CORPORATION will showcase its products for the Drug Delivery System at Booth #717 from May 11 to May 14.
Additionally, Syed Reza, Scientific & Sales Consultant at NOF AMERICA CORPORATION (a subsidiary of NOF CORPORATION), will present on the following topic on May 14.
Presentation Title
Hybrid adjuvant-LNP mRNA Vaccines Elicit Robust CD8+ T-Cells against Neoantigen Tumors and Suppress Tumor Growth
Date & Time
May 14 / 10:35a.m. – 10:50 a.m. (EDT)
Place
IMMUNOTHERAPY / Next-Generation Immunotherapies
Speaker
Syed Reza, Scientific & Sales Consultant at NOF AMERICA CORPORATION
Presentation
Effective mRNA cancer vaccines require lipid nanoparticles (LNPs) that balance cytoplasmic mRNA delivery with immune stimulation. We present a hybrid LNP platform, LNP(OP/EC), that combines two distinct ionizable lipids: COATSOME® SS-OP, for high transfection efficiency, and COATSOME® SS-EC, containing a Vitamin E scaffold for potent adjuvant effects. This hybrid LNP demonstrated specific cellular immunity against neoantigen tumors while minimizing general inflammatory responses.
NOF CORPORATION invites attendees to visit booth #717 to explore its innovative drug delivery solutions and engage with its experts.
For further information or to arrange a meeting, please refer to the following contact information.